Skip to main content

DEA's new telehealth rules are bad news for trans people on testosterone

By them  
   March 28, 2023

The DEA is considering a rule that would end telemedicine prescriptions for controlled substances unless the patient has had an in-person appointment.

Full story

Get the latest on healthcare leadership in your inbox.